Neurorehabilitation and neural repair · 2019 · 54 citations · 41 references
Life SciencesNeurologyNeuroscienceInflammationNeuroimmunologySynaptic PlasticityCytokine BiologyLong-term PotentiationMultiple SclerosisNeural PlasticityNeuroinflammationSynaptic Strength RegulationCerebrospinal Fluid CytokinesHippocampal Long-term PotentiationInflammation-mediated PlasticityNeuroinflammation In Multiple SclerosisNeuroinflammatory CytokinesProinflammatory Cytokine ModulationProinflammatory MediatorsSynaptic Plasticity Disruption
Background: Synaptic plasticity helps in reducing the clinical expression of brain damage and represents a useful mechanism to compensate the negative impact of new brain lesions in multiple sclerosis (MS). Inflammation, altering synaptic plasticity, could negatively influence the disease course in relapsing-remitting MS (RR-MS). Objective: In the present study, we explored whether interleukin (IL)-6, a major proinflammatory cytokine involved in MS pathogenesis, alters synaptic plasticity and affects the ability to compensate for ongoing brain damage. Methods: The effect of IL-6 incubation on long-term potentiation (LTP) induction was explored in vitro , in mice hippocampal slices. We also explored the correlation between the cerebrospinal fluid (CSF) levels of this cytokine and the LTP-like effect induced by the paired associative stimulation (PAS) in a group of RR-MS patients. Finally, we examined the correlation between the CSF levels of IL-6 at the time of diagnosis and the prospective disease activity in a cohort of 150 RR-MS patients. Results: In vitro LTP induction was abolished by IL-6. Consistently, in patients with MS, a negative correlation emerged between IL-6 CSF concentrations and the effect of PAS. In MS patients, longer disease duration before diagnosis was associated with higher IL-6 CSF concentrations. In addition, elevated CSF levels of IL-6 were associated with greater clinical expression of new inflammatory brain lesions, unlike in patients with low or absent IL-6 concentrations, who had a better disease course. Conclusions: IL-6 interfering with synaptic plasticity mechanisms may impair the ability to compensate the clinical manifestation of new brain lesions in RR-MS patients.
41
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
Corticocortical inhibition in human motor cortex.
Takashi Kujirai, M.D. Caramia, John C. Rothwell et al. · The Journal of Physiology · 1993 · 3.1K citations
Induction of plasticity in the human motor cortex by paired associative stimulation